Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medivation Inc    

MEDIVATION INC
Mes dernières consult.
Most popular
  Report  
SummaryNewsCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Medivation Inc : Medivation Announces Participation at Upcoming Investor Conferences

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/30/2013 | 10:34pm CEST

SAN FRANCISCO, CA -- (Marketwired) -- 10/28/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2013 financial results and provide a general business update on November 12, 2013 at 4:30 p.m. Eastern Time. A press release for the third quarter of 2013 will be released after markets close on November 12, 2013.

Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900

Source: Medivation

News Provided by Acquire Media

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIVATION INC
2016Drugmaker Sanofi hungry for deals after earnings beat
RE
2016MEDIVATION : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼..
BU
2016Pfizer Throws Out Plan to Split Into Two Companies
DJ
2016FARUQI & FARUQI, LLP : Announces Filing of a Class Action Lawsuit Against Mediva..
PR
2016EXCLUSIVE - GW PHARMACEUTICALS HIRES : sources
RE
2016MEDIVATION SHAREHOLDER NOTICE : Faruqi & Faruqi, LLP Announces the Investigation..
PR
2016Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation,..
BU
2016Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale o..
BU
2016SHAREHOLDER UPDATE : Brodsky & Smith, LLC Announces an Investigation of The Boar..
PR
2016Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale o..
BU
More news
News from SeekingAlpha
2017Vantage Point - Are Charities The Best Way To Pay For Costly Drugs? 
2017Axovant Sciences announces appointment of Dr. David Hung as CEO and expansion.. 
2017BIOTECH FORUM DAILY DIGEST : Biotech Closes Above Resistance Levels. Icahn Getti.. 
2017BIOTECH FORUM DAILY DIGEST : Buyout Rumors On The Rise; Aratana Therapeutics' De.. 
2017Pfizer May Be Another IBM 
Chart MEDIVATION INC
Duration : Period :
Medivation Inc Technical Analysis Chart | US58501N1019 | 4-Traders
Managers
NameTitle
Elizabeth Barrett Chief Executive Officer
Kim D. Blickenstaff Chairman
Anne Bowdidge Senior Director-Investor Relations
Sector and Competitors
1st jan.Capitalization (M$)
MEDIVATION INC0
GILEAD SCIENCES3.31%96 498
VERTEX PHARMACEUTICALS5.89%40 290
REGENERON PHARMACEUTICALS-15.95%34 033
GENMAB20.17%12 599
BEIGENE LTD (ADR)73.75%9 087